Generics 31

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Methylprednisolone sodium succinate manufacturers

31 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

31 products found

methylprednisolone sodium succinate

Powder and solvent for solution for injection 40 mg, 125 mg, 1000 mg - 10 ml, 20 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO, India
Registered in
India
Available for
Licensing with supply, Distribution only, Technology transfer
MAs available in
India
Manufacturer #22627

This CTD dossier owner and manufacturer was founded in 2007 and has two manufacturing facilities strategically located in India. They boast over 1,800 products spanning a range of therapeutic areas, including those focused on dermatology, pain management, and possibly central nervous system disorders based on the listed divisions. The company produces both prescription medications and over-the-counter drugs, utilizing diverse dosage forms such as tablets and capsules. They maintain a strong national network for distribution and a global presence. GMP certifications are likely held due to their focus on quality manufacturing practices.

Manufacturer usually replies in 4 days

methylprednisolone sodium succinate

Injection 40 mg, 125 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19861
This company specializes in the wholesale distribution of pharmaceutical products, primarily tablets, capsules, injections, and oral solutions, serving the South Asian market. Established within the last decade, they have gained recognition for offering a wide range of products, including antibiotics and formulations for diabetes and heart conditions. They operate under GMP (Good Manufacturing Practice) standards, ensuring quality and safety. While specific product patents are not mentioned, the company's focus on quality and extensive product portfolio demonstrate its commitment to the industry.

Manufacturer usually replies in 3 days

methylprednisolone sodium succinate

Injection 1 gm

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19740
This pharmaceutical company, established in 2005, offers a range of products including prescription medications, over-the-counter drugs, medical devices, and supplements. They focus on key therapy areas such as hepatology and pain management, delivering these through various dosage forms like syrups, tablets, injections, capsules, and ointments. Operating across North America, the EU, and other regions, this company is WHO-GMP and ISO 9001-2015 certified. They have a strong track record of success, evidenced by their partnerships with leading pharmaceutical companies and awards recognizing their commitment to quality.

Manufacturer usually replies in 1 days

Want to see all 31 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Methylprednisolone Sodium Succinate Manufacturers

Methylprednisolone sodium succinate is a corticosteroid medication that is useful in reducing inflammation. WhichMainly leads to a reduction in pain and improvement of a variety of symptoms associated with injury, inflammation, and allergy. This drug is marketed with the Brand Name SOLU-MEDROL. Methylprednisolone sodium succinate is used for emergency or acute type conditions where a rapid response is required. The main uses of methylprednisolone sodium succinate include the Severe allergic reactions– Methylprednisolone sodium succinate should be given after immediate treatment with adrenaline or an Epipen. Status asthmaticus (severe asthma attacks)- Although methylprednisolone sodium succinate does not act immediately it should still be given in the event of an acute attack. Suppression of transplant rejection. Cerebral edema (swelling due to fluid). Inflammatory bowel disease in severely ill patients. Systemic lupus erythematosus (a multi-system inflammatory disorder). Rheumatic disorders– Useful in acute attacks. Certain types of meningitis and pneumonia are also considered. This medication basically means that it is a steroid medication produced in the center (cortex) of the adrenal gland. Methylprednisolone has a specific ‘glucocorticoid’ effect meaning that it predominantly acts to reduce the body normal inflammation and immune responses which is achieved by modifying the nature of various genes which lies within the tissue cells. Like the other steroids, methylprednisolone also causes mild water and salt retention in the kidneys. However, this effect has far less potency toward it. Methylprednisolone Sodium Succinate is supplied as a dry white powder which is required to dissolve in water before administration. Methylprednisolone is administered either intramuscularly or intravenously. This medication should be administered under the supervision of a medical practitioner or health care professional. Methylprednisolone Sodium Succinate is available in two different dosage strengths 500mg (in a 20mL glass vial) or 1000mg (in a 30mL glass vial). Methylprednisolone Sodium Succinate vials are recommended to be stored at 20° C to 25° C (68° F - 77° F)

Wholesale Price of Methylprednisolone Sodium Succinate

The wholesale price of Methylprednisolone Sodium Succinate injectable powder for injection (1 g preservative-free) is around $72 for a supply of 1 powder for injection, The cost for Methylprednisolone Sodium Succinate injectable powder for injection (40 g preservative-free) is around $ 167.29 for a supply of 25 powder for injection and the per-unit cost comes at as low as $ 6.69.

Methylprednisolone Sodium Succinate - Mechanism of action:

Methylprednisolone binds and activates specific nuclear receptors, which are resulting in altered gene expression by the inhibition of proinflammatory cytokine production. Produced agent also decreases the number of circulating lymphocytes, induces cell differentiation, and stimulates apoptosis in sensitive tumour cell populations. It also acts as in to various ways to decrease the inflammatory cycle including: dampening the inflammatory cytokine inhibits the activation of T cells, which decreases the extravasation of immune cells into the central nervous system which in turn facilitates the apoptosis of activated immune cells, and thereby indirectly decreases the cytotoxic effects of nitric oxide and tumour necrosis.

Finding Methylprednisolone Sodium Succinate Manufacturers and Suppliers

To find an honest partner in our business is one of the big tests and to defeat that test and to make one’s work/life easy in finding the honest manufacturer and supplier of Methylprednisolone Sodium Succinate one can visit the Pipelinepharma website which helps the buyer in finding the dependable manufacturers and suppliers of Methylprednisolone Sodium Succinate. Pipelinepharma, which is a business-to-business (B2B) licensing marketplace for pharmaceutical products, quickly connects proprietor with the consumers for the business Development. The buyer can filter the product names in user familiar and unified search engine by its country, category, therapeutic area, forms, dossier, and its status, regulatory filings, approvals, and more.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible